Todas las investigaciones
ReclutamientoFarmacología Humana (Fase I) - Primera administración en humanosIntervencionista

A Study to Assess the Safety of RG6496 in Huntington’s Disease Gene Expansion Carriers with the Selected Genetic Variant (POINT-HD)

This research study, called POINT-HD, is investigating a new medicine, RG6496, for individuals who have the genetic change that causes Huntington's disease. Crucially, this is the first time this experimental medicine will be given to people. The main purpose of this initial stage, often called Phase I, is to carefully observe and understand how safe the medicine is in humans. Researchers will be looking to see if there are any unwanted side effects and how the body reacts to the new drug. This type of study is a vital first step in developing new treatments for serious conditions like Huntington's disease, helping scientists decide if it’s safe enough to study further.

De un vistazo

Estado
Reclutamiento
Fase
Farmacología Humana (Fase I) - Primera administración en humanos
Patrocinador
F. Hoffmann-La Roche AG
Objetivo de inscripción
43
Inicio
11 de mayo de 2026

¿De qué trata este estudio?

This research is looking into a new medicine called RG6496. It’s for people who carry the genetic fault that can lead to Huntington’s disease. Huntington's is a condition that affects the brain and can cause uncontrolled movements, problems with thinking, and changes in mood.

This particular study is a very early step in testing the new medicine. It's the first time RG6496 will be given to people, so the main aim is to check its safety and how the body handles it. This is really important because before any medicine can be tested to see if it works, we need to be as sure as possible that it won't cause serious harm.

Finding new ways to treat or even prevent conditions like Huntington's disease is a big challenge. Studies like this one are essential for gathering the initial information needed to see if a potential new treatment is promising enough to move on to larger studies in the future.

Puntos clave

  • This study is testing a new medicine (RG6496) for Huntington's disease.
  • It's the very first time this medicine is being given to people.
  • The main aim is to check how safe the medicine is.
  • Only adults who carry the Huntington's disease gene can take part.
  • La participación implica visitas regulares a la clínica y un seguimiento cercano.
  • You can stop participating at any time without issue.

¿Quién puede ser elegible?

To be able to take part in this study, you would need to be an adult, aged 18 or older. There is no upper age limit for joining.

Crucially, you would need to be someone who carries the specific gene change that causes Huntington's disease. The researchers are looking for people who have certain genetic characteristics related to this condition.

Both men and women are welcome to take part in this study, provided they meet all the other requirements. The research team will review your medical history and test results to see if you're a good fit for this particular trial.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tienes 18 años o más?
  2. Have you been told you carry the gene for Huntington's disease?
  3. Are you willing and able to attend regular clinic appointments?
  4. Are you comfortable with receiving an experimental medicine?
  5. Do you want to contribute to medical research?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you decide to take part, you would receive the study medicine, RG6496. Since this is the first time it’s being given to humans, you would be closely monitored by the study doctors and nurses. This would involve regular visits to the clinic for health checks, blood tests, and other assessments to make sure you are safe and to see how your body is reacting to the medicine. The total duration of your involvement in the study would be explained in detail by the research team.

Riesgos y beneficios potenciales

Taking part in any medical study has potential benefits and risks. A potential benefit could be contributing to the development of a new medicine that might help people with Huntington's disease in the future. However, because this is a first-time-in-human study, the direct benefit to you specifically isn't guaranteed and is unlikely at this early stage. Potential risks include experiencing side effects from the new medicine, which could be mild or, less commonly, more serious. All risks will be fully explained before you agree to take part. Remember, you can decide to stop participating in the study at any time, for any reason, without it affecting your usual medical care.

Ubicaciones (6)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Italia
  • —
    No verificado
    Polonia
  • —
    No verificado
    Dinamarca
  • —
    No verificado
    Alemania
  • —
    No verificado
    Portugal
  • —
    No verificado
    España

Preguntas comunes

¿Qué es la enfermedad de Huntington?

Huntington's disease is a serious condition that affects the brain, leading to problems with movement, thinking, and mental health over time.

What is a 'gene expansion carrier'?

This means someone who has the specific genetic change (a 'gene expansion') that is known to cause Huntington's disease.

What does 'Phase I study' mean?

It means this is the very first time the medicine is being tested in people. The main goal is to check for safety and how the body handles it, not yet to see if it works.

Will I definitely get better if I join this study?

No, this study is primarily about checking the safety of a new medicine, not about treating your symptoms at this stage. Any direct benefit to you is not expected.

¿Puedo abandonar el estudio si cambio de opinión?

Yes, absolutely. You can withdraw from the study at any point, and your decision will not affect your ongoing medical care.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A Study to Assess the Safety of RG6496 in Huntington’s Disea…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.